Back to top

Aspirin for primary prevention of cardiovascular and all-cause mortality events in diabetes: Updated meta-analysis of randomized controlled trials

Citation

Kunutsor SK, Seidu S, Khunti K. Aspirin for primary prevention of cardiovascular and all-cause mortality events in diabetes: Updated meta-analysis of randomized controlled trials. Diabet Med. 2016. 

Abstract

To evaluate the benefits and harms of aspirin for the primary prevention of cardiovascular disease and all-cause mortality eventsin people with diabetes by conducting a systematic review and meta-analysis.

Link